Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Wendy Armstrong

Concepts (371)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
68
2026
3195
5.610
 Why?
Epidemics
7
2026
96
2.220
 Why?
Communicable Diseases
8
2023
166
1.810
 Why?
Anti-Retroviral Agents
5
2019
251
1.620
 Why?
Anti-HIV Agents
14
2026
912
1.540
 Why?
Viral Load
14
2026
526
1.140
 Why?
Infectious Disease Medicine
2
2017
12
1.040
 Why?
Continuity of Patient Care
5
2022
297
0.950
 Why?
AIDS-Related Opportunistic Infections
5
2019
130
0.870
 Why?
HIV
13
2023
251
0.860
 Why?
Internal Medicine
3
2016
279
0.860
 Why?
Social Stigma
2
2024
173
0.820
 Why?
Immune Reconstitution Inflammatory Syndrome
2
2019
20
0.740
 Why?
Internship and Residency
6
2021
1269
0.680
 Why?
Pre-Exposure Prophylaxis
3
2024
269
0.640
 Why?
Drug Monitoring
2
2016
401
0.640
 Why?
Antiretroviral Therapy, Highly Active
6
2019
279
0.620
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2020
19
0.620
 Why?
Adenine
2
2020
339
0.610
 Why?
Diagnostic Tests, Routine
2
2021
107
0.600
 Why?
Acquired Immunodeficiency Syndrome
7
2022
237
0.590
 Why?
Humans
97
2026
145785
0.580
 Why?
Consumer Advocacy
1
2018
12
0.560
 Why?
United States
27
2026
16126
0.540
 Why?
Career Choice
3
2018
235
0.540
 Why?
Lost to Follow-Up
2
2017
20
0.540
 Why?
HIV-1
8
2026
908
0.520
 Why?
Delivery of Health Care
4
2021
948
0.510
 Why?
Health Policy
3
2023
400
0.500
 Why?
Health Services Accessibility
4
2024
1101
0.500
 Why?
CD4 Lymphocyte Count
6
2020
280
0.480
 Why?
Georgia
10
2024
79
0.470
 Why?
Substance-Related Disorders
6
2021
1103
0.460
 Why?
Medication Adherence
2
2017
540
0.460
 Why?
Rilpivirine
2
2026
10
0.450
 Why?
Antimicrobial Stewardship
3
2023
130
0.440
 Why?
Disease Management
1
2019
653
0.440
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2014
9
0.430
 Why?
Urban Population
1
2017
494
0.410
 Why?
Biomedical Research
2
2018
719
0.400
 Why?
Bone Diseases
1
2014
61
0.400
 Why?
Financing, Government
1
2014
53
0.400
 Why?
Metabolic Diseases
1
2014
114
0.380
 Why?
Drug Resistance, Viral
2
2005
126
0.380
 Why?
Patient Acceptance of Health Care
2
2017
883
0.380
 Why?
Rural Population
1
2017
661
0.360
 Why?
Ventriculostomy
1
2012
24
0.360
 Why?
Medication Errors
1
2012
85
0.350
 Why?
Chronic Pain
3
2021
292
0.340
 Why?
Central Nervous System Diseases
1
2012
74
0.330
 Why?
Mycoses
1
2012
88
0.330
 Why?
Ambulatory Care
2
2021
610
0.330
 Why?
Prostheses and Implants
1
2012
137
0.320
 Why?
Disease Transmission, Infectious
1
2011
69
0.320
 Why?
Gram-Positive Bacterial Infections
2
2008
72
0.310
 Why?
Critical Care
1
2016
702
0.310
 Why?
Cellulitis
2
2011
54
0.310
 Why?
Microbiology
3
2014
24
0.310
 Why?
Bacterial Infections
1
2012
247
0.300
 Why?
Physicians
5
2019
956
0.300
 Why?
Analgesics, Opioid
5
2021
1154
0.290
 Why?
Dermatitis
1
2008
20
0.290
 Why?
Patient-Centered Care
1
2014
547
0.280
 Why?
Medical Informatics
1
2009
100
0.280
 Why?
Male
41
2026
73012
0.280
 Why?
Female
42
2026
79045
0.280
 Why?
Global Health
2
2018
403
0.280
 Why?
Gram-Negative Bacterial Infections
1
2008
49
0.280
 Why?
Adult
33
2026
40882
0.270
 Why?
Education, Medical, Graduate
5
2023
562
0.260
 Why?
Africa, Eastern
2
2017
12
0.260
 Why?
Middle Aged
32
2026
36309
0.260
 Why?
Information Dissemination
1
2009
224
0.260
 Why?
Delayed Diagnosis
2
2026
100
0.260
 Why?
AIDS Vaccines
2
2005
53
0.260
 Why?
Periodicals as Topic
1
2009
209
0.250
 Why?
Viremia
2
2026
160
0.240
 Why?
Pneumonia, Pneumocystis
4
2015
34
0.240
 Why?
Developing Countries
3
2017
317
0.240
 Why?
Pyridones
2
2026
209
0.230
 Why?
Mycobacterium chelonae
1
2005
8
0.230
 Why?
Internet
2
2014
693
0.230
 Why?
Curriculum
5
2023
1074
0.230
 Why?
Databases, Factual
2
2019
1491
0.220
 Why?
Exosomes
2
2016
104
0.210
 Why?
Skin
1
2008
754
0.200
 Why?
Fellowships and Scholarships
4
2023
354
0.190
 Why?
Meningoencephalitis
1
2003
24
0.190
 Why?
Cost-Benefit Analysis
3
2021
644
0.190
 Why?
West Nile virus
1
2003
41
0.190
 Why?
Bacteria
1
2008
766
0.190
 Why?
Practice Guidelines as Topic
3
2019
1582
0.180
 Why?
Interviews as Topic
2
2017
916
0.180
 Why?
Anti-Infective Agents
3
2015
232
0.180
 Why?
Pain Management
3
2021
411
0.170
 Why?
Simulation Training
1
2023
136
0.170
 Why?
Colony-Stimulating Factors
1
2001
37
0.170
 Why?
Coronary Artery Bypass
1
2003
268
0.170
 Why?
Pandemics
4
2026
1711
0.170
 Why?
Erythrocyte Transfusion
1
2003
225
0.170
 Why?
Mycobacterium Infections, Nontuberculous
1
2005
339
0.160
 Why?
Contact Tracing
1
2020
26
0.160
 Why?
Obesity
1
2014
3118
0.160
 Why?
Prescription Drug Misuse
1
2021
53
0.160
 Why?
Cities
4
2022
139
0.160
 Why?
Mass Screening
2
2020
1361
0.160
 Why?
Models, Theoretical
2
2021
560
0.160
 Why?
Erythropoietin
1
2001
100
0.150
 Why?
Registries
2
2019
2410
0.150
 Why?
Antibodies, Monoclonal, Humanized
1
2026
992
0.150
 Why?
Sexual and Gender Minorities
1
2024
265
0.150
 Why?
Policy
1
2021
149
0.150
 Why?
Life Expectancy
1
2020
73
0.150
 Why?
Interleukin-2
1
2001
440
0.150
 Why?
Heart Diseases
1
2022
341
0.140
 Why?
Alanine
1
2020
169
0.140
 Why?
Fever of Unknown Origin
1
1999
13
0.140
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2019
38
0.140
 Why?
Cross-Sectional Studies
5
2021
5925
0.140
 Why?
Cohort Studies
7
2019
6033
0.140
 Why?
Health Equity
1
2021
133
0.140
 Why?
Mentors
2
2018
217
0.140
 Why?
Comorbidity
2
2020
1662
0.140
 Why?
Prevalence
5
2024
2875
0.140
 Why?
Microbial Sensitivity Tests
3
2016
365
0.140
 Why?
Tenofovir
1
2020
301
0.130
 Why?
Sexually Transmitted Diseases
1
2020
168
0.130
 Why?
Physician Assistants
1
2019
101
0.130
 Why?
Capital Financing
1
2017
7
0.130
 Why?
Patient Identification Systems
1
2017
16
0.130
 Why?
Sustained Virologic Response
1
2017
46
0.130
 Why?
Africa
1
2017
119
0.130
 Why?
Nurse Practitioners
1
2019
141
0.120
 Why?
Hospitalization
4
2020
2461
0.120
 Why?
Risk Factors
7
2020
10919
0.120
 Why?
Anti-Bacterial Agents
4
2011
1925
0.120
 Why?
Financing, Personal
1
2016
27
0.120
 Why?
Viral Tropism
1
2016
36
0.120
 Why?
Research Personnel
1
2018
185
0.120
 Why?
Case Management
1
2016
68
0.120
 Why?
Motivation
2
2017
602
0.110
 Why?
Hospitals
2
2021
733
0.110
 Why?
Diketopiperazines
2
2026
23
0.110
 Why?
Opioid-Related Disorders
2
2021
605
0.110
 Why?
Pneumonia, Viral
1
2020
391
0.110
 Why?
Coronavirus Infections
1
2020
384
0.110
 Why?
Drug Utilization Review
1
2015
61
0.110
 Why?
Organizational Policy
1
2015
78
0.110
 Why?
HIV Protease Inhibitors
1
2015
69
0.110
 Why?
Online Systems
1
2014
20
0.110
 Why?
Esophageal Diseases
1
2015
30
0.110
 Why?
Candidiasis
1
2015
64
0.110
 Why?
Cytosol
1
2015
213
0.110
 Why?
Time-to-Treatment
1
2017
251
0.100
 Why?
Pregnancy Complications, Infectious
1
2019
440
0.100
 Why?
Patient Navigation
1
2016
126
0.100
 Why?
Alcoholism
1
2021
826
0.100
 Why?
Retrospective Studies
8
2026
17330
0.100
 Why?
Organophosphates
1
2015
179
0.100
 Why?
Drug Interactions
1
2015
405
0.100
 Why?
Healthcare Disparities
1
2020
736
0.100
 Why?
Ambulatory Care Facilities
1
2016
269
0.100
 Why?
Patient Readmission
1
2019
773
0.100
 Why?
DNA, Viral
2
2012
356
0.090
 Why?
Health Plan Implementation
1
2014
141
0.090
 Why?
Dihydropteroate Synthase
2
2004
3
0.090
 Why?
Medication Reconciliation
1
2012
32
0.090
 Why?
Leukocytes, Mononuclear
1
2015
574
0.090
 Why?
Incidence
2
2021
2934
0.090
 Why?
Oligopeptides
1
2014
267
0.090
 Why?
Telemedicine
1
2021
967
0.090
 Why?
Pilot Projects
2
2017
1898
0.090
 Why?
Myocardial Infarction
2
2019
1211
0.090
 Why?
HIV Antibodies
1
2012
61
0.090
 Why?
Longitudinal Studies
2
2019
2968
0.090
 Why?
Socioeconomic Factors
2
2020
1327
0.090
 Why?
Primary Health Care
2
2019
1737
0.090
 Why?
Mycobacterium haemophilum
1
2011
1
0.090
 Why?
Aged
8
2022
26217
0.090
 Why?
Parasitic Diseases
1
2011
8
0.080
 Why?
Research
1
2014
431
0.080
 Why?
Mycobacterium Infections
1
2011
55
0.080
 Why?
Cytomegalovirus
1
2012
168
0.080
 Why?
Pneumocystis
2
2001
8
0.080
 Why?
Catheter-Related Infections
1
2012
96
0.080
 Why?
Simian Immunodeficiency Virus
1
2011
93
0.080
 Why?
Electronic Health Records
1
2019
1202
0.080
 Why?
Simian Acquired Immunodeficiency Syndrome
1
2011
92
0.080
 Why?
Health Care Costs
1
2014
425
0.080
 Why?
Geography
1
2011
187
0.080
 Why?
Cytokines
2
2016
2069
0.080
 Why?
Education, Medical, Undergraduate
1
2013
208
0.080
 Why?
Surveys and Questionnaires
5
2023
6085
0.080
 Why?
Cytomegalovirus Infections
1
2012
206
0.080
 Why?
Sulfonamides
1
2014
583
0.080
 Why?
Rectum
1
2011
182
0.080
 Why?
Pyridines
1
2014
609
0.070
 Why?
Antibodies, Neutralizing
1
2012
340
0.070
 Why?
Adolescent
5
2021
22577
0.070
 Why?
Desiccation
1
2009
26
0.070
 Why?
Deep Brain Stimulation
1
2012
220
0.070
 Why?
Drug Therapy, Combination
3
2014
1043
0.070
 Why?
Colon
1
2011
309
0.070
 Why?
Education, Medical, Continuing
1
2009
134
0.070
 Why?
Emigrants and Immigrants
1
2011
158
0.070
 Why?
Syphilis, Cutaneous
1
2007
3
0.070
 Why?
Immunoglobulin G
1
2012
892
0.070
 Why?
Dendritic Cells
1
2011
501
0.070
 Why?
Specimen Handling
1
2009
183
0.060
 Why?
Hepacivirus
1
2009
242
0.060
 Why?
Plasma
1
2009
223
0.060
 Why?
B-Lymphocytes
1
2012
872
0.060
 Why?
Risk Assessment
3
2019
3752
0.060
 Why?
Treatment Outcome
6
2024
11794
0.060
 Why?
Young Adult
3
2021
14254
0.060
 Why?
Hepatitis C
1
2009
256
0.060
 Why?
Acetamides
1
2026
41
0.060
 Why?
Indazoles
1
2026
85
0.060
 Why?
HIV-2
1
2005
18
0.050
 Why?
Diagnosis, Differential
2
2007
1512
0.050
 Why?
Dapsone
2
2004
8
0.050
 Why?
Sex Factors
1
2011
2110
0.050
 Why?
CD4-Positive T-Lymphocytes
1
2011
1146
0.050
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
2
2004
43
0.050
 Why?
Patient Education as Topic
1
2009
777
0.050
 Why?
Pneumocystis carinii
1
2004
12
0.050
 Why?
Chronic Disease
2
2012
1812
0.050
 Why?
Mediastinitis
1
2003
3
0.050
 Why?
Virulence
1
2005
278
0.050
 Why?
Vancomycin Resistance
1
2003
16
0.050
 Why?
Enterococcus faecium
1
2003
22
0.050
 Why?
Delayed-Action Preparations
1
2024
189
0.050
 Why?
Wound Healing
1
2005
355
0.050
 Why?
Fatal Outcome
1
2003
305
0.050
 Why?
Liver Failure
1
2002
83
0.040
 Why?
Biopsy
1
2005
1082
0.040
 Why?
Cryptococcosis
1
2001
31
0.040
 Why?
Transplantation, Homologous
1
2002
419
0.040
 Why?
Dental Care
1
2021
25
0.040
 Why?
Intracranial Hypertension
1
2001
42
0.040
 Why?
Coronary Disease
2
2003
382
0.040
 Why?
Blood
2
2012
107
0.040
 Why?
Naphthoquinones
1
2001
20
0.040
 Why?
Cytochrome b Group
1
2001
22
0.040
 Why?
Quality-Adjusted Life Years
1
2021
125
0.040
 Why?
Adipose Tissue
1
2005
645
0.040
 Why?
Mutation
2
2004
4090
0.040
 Why?
Time Factors
3
2019
7134
0.040
 Why?
Patient Outcome Assessment
1
2021
130
0.040
 Why?
Meningitis
1
2001
80
0.040
 Why?
Renal Insufficiency
1
2002
172
0.040
 Why?
Neutropenia
1
2001
154
0.040
 Why?
Antifungal Agents
1
2001
152
0.040
 Why?
Trust
1
2021
158
0.040
 Why?
Prospective Studies
1
2012
8078
0.040
 Why?
Personal Satisfaction
1
2021
221
0.040
 Why?
Anemia
1
2001
191
0.040
 Why?
JC Virus
1
2019
23
0.040
 Why?
Spinal Diseases
1
1999
50
0.040
 Why?
Polyomavirus Infections
1
2019
30
0.040
 Why?
Antiviral Agents
1
2005
769
0.040
 Why?
Boston
1
2019
93
0.040
 Why?
Asymptomatic Infections
1
2019
37
0.040
 Why?
Abscess
1
1999
77
0.040
 Why?
Polymerase Chain Reaction
3
2011
1043
0.040
 Why?
Esophageal Stenosis
1
1999
60
0.040
 Why?
Antibodies, Monoclonal
1
2026
1505
0.040
 Why?
Insurance, Health
1
2021
311
0.030
 Why?
Training Support
1
2018
35
0.030
 Why?
Benchmarking
1
2019
191
0.030
 Why?
Health Status Disparities
1
2021
321
0.030
 Why?
Preceptorship
1
2018
63
0.030
 Why?
Recombinant Proteins
1
2001
1368
0.030
 Why?
Heart-Assist Devices
1
2003
568
0.030
 Why?
Substance Abuse Detection
1
2019
110
0.030
 Why?
Dyslipidemias
1
2019
184
0.030
 Why?
Multicenter Studies as Topic
1
2019
413
0.030
 Why?
Patient Satisfaction
1
2021
712
0.030
 Why?
Hospitals, Public
1
2017
30
0.030
 Why?
Drug Administration Schedule
1
2019
782
0.030
 Why?
Prenatal Care
1
2019
309
0.030
 Why?
Odds Ratio
1
2019
1083
0.030
 Why?
Medicare
1
2022
904
0.030
 Why?
Ultracentrifugation
1
2016
50
0.030
 Why?
Postpartum Period
1
2019
373
0.030
 Why?
Public Health Surveillance
1
2016
83
0.030
 Why?
Needs Assessment
1
2018
403
0.030
 Why?
Multivariate Analysis
1
2019
1547
0.030
 Why?
Virion
1
2016
108
0.030
 Why?
Stents
1
1999
564
0.030
 Why?
Motivational Interviewing
1
2016
121
0.030
 Why?
Guideline Adherence
1
2019
587
0.030
 Why?
Neopterin
1
2014
13
0.030
 Why?
Darunavir
1
2014
20
0.030
 Why?
Atazanavir Sulfate
1
2014
42
0.030
 Why?
Societies, Medical
1
2018
900
0.030
 Why?
Ritonavir
1
2014
75
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2016
849
0.020
 Why?
Antigens, CD
1
2016
558
0.020
 Why?
Randomized Controlled Trials as Topic
1
2019
1752
0.020
 Why?
Biomarkers
2
2016
4302
0.020
 Why?
Blood Proteins
1
2014
239
0.020
 Why?
Qualitative Research
1
2020
1683
0.020
 Why?
Transplantation
1
2012
33
0.020
 Why?
Smoking
1
2019
1477
0.020
 Why?
Inpatients
1
2016
553
0.020
 Why?
Rifabutin
1
2011
7
0.020
 Why?
Clarithromycin
1
2011
24
0.020
 Why?
Ofloxacin
1
2011
17
0.020
 Why?
Receptors, Immunologic
1
2012
209
0.020
 Why?
Integrins
1
2011
90
0.020
 Why?
Macaca mulatta
1
2011
186
0.020
 Why?
Hypertension
1
2019
1276
0.020
 Why?
Quality of Life
1
2023
3211
0.020
 Why?
Data Interpretation, Statistical
1
2012
368
0.020
 Why?
Programmed Cell Death 1 Receptor
1
2012
266
0.020
 Why?
RNA, Viral
1
2014
693
0.020
 Why?
Practice Patterns, Physicians'
1
2019
1372
0.020
 Why?
Immunocompromised Host
1
2011
202
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
751
0.020
 Why?
Blotting, Western
1
2011
1184
0.020
 Why?
Health Promotion
1
2015
775
0.020
 Why?
Cells, Cultured
1
2016
4151
0.020
 Why?
False Negative Reactions
1
2007
61
0.020
 Why?
Feces
1
2011
496
0.020
 Why?
Protein Binding
1
2014
2240
0.020
 Why?
Flow Cytometry
1
2011
1165
0.020
 Why?
Lymphocyte Activation
1
2011
1133
0.020
 Why?
Neoplasms
1
2002
2913
0.020
 Why?
Cardiovascular Diseases
1
2019
2191
0.020
 Why?
Pregnancy
1
2019
7216
0.010
 Why?
Gene Expression Profiling
1
2011
1777
0.010
 Why?
Genotype
1
2009
1857
0.010
 Why?
T-Lymphocytes
1
2012
1998
0.010
 Why?
Chemoprevention
1
2004
92
0.010
 Why?
China
1
2004
274
0.010
 Why?
Infant
1
2016
10091
0.010
 Why?
Atovaquone
1
2001
4
0.010
 Why?
Survival
1
2001
38
0.010
 Why?
Child, Preschool
1
2016
11868
0.010
 Why?
Ubiquinone
1
2001
35
0.010
 Why?
Reproducibility of Results
1
2009
3418
0.010
 Why?
Gene Amplification
1
2001
118
0.010
 Why?
Cardiomyopathy, Dilated
1
2003
356
0.010
 Why?
Sulfones
1
2000
127
0.010
 Why?
Epidural Space
1
1999
17
0.010
 Why?
Postoperative Complications
2
2003
2977
0.010
 Why?
Radiotherapy, Adjuvant
1
1999
222
0.010
 Why?
Animals
2
2011
38106
0.010
 Why?
Recurrence
1
2001
1139
0.010
 Why?
Polymorphism, Genetic
1
2001
615
0.010
 Why?
Radiation Injuries
1
1999
149
0.010
 Why?
Esophagus
1
1999
262
0.010
 Why?
Heart Transplantation
1
2003
680
0.010
 Why?
Molecular Sequence Data
1
2001
2883
0.010
 Why?
Child
1
2016
22740
0.010
 Why?
Esophageal Neoplasms
1
1999
348
0.010
 Why?
Carcinoma, Squamous Cell
1
1999
641
0.010
 Why?
Follow-Up Studies
1
2003
5428
0.010
 Why?
Case-Control Studies
1
2001
3634
0.010
 Why?
Angina Pectoris
1
1971
76
0.010
 Why?
Coronary Vessels
1
1971
246
0.000
 Why?
Tomography, X-Ray Computed
1
1999
2770
0.000
 Why?
Aorta
1
1971
442
0.000
 Why?
Magnetic Resonance Imaging
1
1999
3916
0.000
 Why?
Angiocardiography
1
1971
1
0.000
 Why?
Methods
1
1971
68
0.000
 Why?
Extracorporeal Circulation
1
1971
14
0.000
 Why?
Saphenous Vein
1
1971
37
0.000
 Why?
Transplantation, Autologous
1
1971
301
0.000
 Why?
Emergencies
1
1971
174
0.000
 Why?
Armstrong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (371) concept(s)
_
Co-Authors Expand Description
See all (11) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)